Skip to main
CGTX
CGTX logo

Cognition Therapeutics (CGTX)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Cognition Therapeutics (CGTX) Stock

About Cognition Therapeutics (CGTX)

Cognition Therapeutics, Inc. is a clinical stage neuroscience company which engages in developing drugs that help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders. It offers the CT1812 which aims to restore the damaged cellular processes that drive diseases such as Alzheimer’s disease, dry age-related macular degeneration, geographic atrophy and other co...read more
Market cap$18.49M
Today's volume1.1M
Revenue (TTM)
Avg. daily volume1.06M
EBITDA (TTM)-$53.39M
Open$0.30
Price / earnings ratio-0.41x
Today's range$0.29 - $0.32
Debt / equity3.86x
52 week range$0.22 - $2.54
5 year debt / equity-18.81x
Beta (LTM)1.49x
Interest coverage-2158.64x
Dividend & yield$0.00 (0.00%)
Current ratio2.09x
Ex-dividend date
Next earningsAug 7, 2025
Dividend payable date

Cognition Therapeutics Stock Rating

What analysts recommend for CGTX stock, on a scale from 1(buy) to 5(sell).
Strong Buy
Strong Buy 71%
Buy 29%
Hold 0%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 15, 2025, the market cap for CGTX stock is $18.5M

The current P/E ratio for CGTX stock is -0.41

The 52-week high for CGTX stock is $2.54. The current CGTX stock price $undefined is 100.00% below its 52-week high

The 52-week low for CGTX stock is $0.22. The current CGTX stock price $undefined has increased 100.00% from its 52-week low

No, the CGTX stock does not pay dividends to its shareholders

The target price for CGTX stock is $7.07 based on the average of what a group of analyst think CGTX stock could be worth at a future date. This is not a prediction by Public.com

How to buy CGTX stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in CGTX stock

    Navigate to the Explore page. Then, type CGTX into the search bar. When you see CGTX stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased CGTX stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Cognition Therapeutics Stock Earnings

The value each CGTX share was expected to gain vs. the value that each CGTX share actually gained.

Cognition Therapeutics (CGTX) reported Q1 2025 earnings per share (EPS) of -$0.14, missing estimates of -$0.12 by 16.67%. In the same quarter last year, Cognition Therapeutics's earnings per share (EPS) was -$0.27. Cognition Therapeutics is expected to release next earnings on 08/07/2025, with an earnings per share (EPS) estimate of $0.

Buy Cognition Therapeutics (CGTX) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.